NVDA
NVIDIA Corporation
NVDA has the edge over RXT overall, supported by stronger valuation and stronger fundamentals.
RXT
Rackspace Technology, Inc.
RXT trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
RXT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
RXT's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
RXT PE Valuation
RXT has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
NVDA has the edge over RXT on the outlook, with more favorable earnings and revenue expectations.
RXT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect RXT's losses to grow, with revenue holding steady.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over RXT on earnings quality, reporting a profit while its opponent remains loss making.
RXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.58 | +$0.44 |
| Q2 2026 | -$0.65 | +$0.91 |
| Q1 2026 | -$0.61 | +$0.61 |
| Q4 2025 | -$0.95 | +$2.87 |
| Q3 2025 | -$1.02 | +$2.44 |
| Q2 2025 | -$1.56 | +$2.13 |
| Q1 2025 | -$1.22 | +$2.71 |
| Q4 2024 | -$3.82 | +$0.07 |
RXT is still losing money, but far less than before: $0.58 per share over the past year, against $6.50 at its worst in early 2023.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over RXT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over RXT on profitability, with a higher operating margin.
RXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $609.1M | -9.3% |
| Q2 2026 | $670.1M | +0.6% |
| Q1 2026 | $678.1M | +1.9% |
| Q4 2025 | $682.8M | -0.4% |
| Q3 2025 | $671.2M | -0.7% |
| Q2 2025 | $666.3M | -2.7% |
| Q1 2025 | $665.4M | -3.7% |
| Q4 2024 | $685.6M | -4.7% |
RXT's revenue fell from its 2022 peak and has held roughly level since: $609M last quarter, down 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2% | +3 points |
| Q2 2026 | -5% | -1.2 points |
| Q1 2026 | -2.6% | +3.1 points |
| Q4 2025 | -0.5% | +3.7 points |
| Q3 2025 | -5% | +21 points |
| Q2 2025 | -3.8% | +4.1 points |
| Q1 2025 | -5.8% | +89 points |
| Q4 2024 | -4.2% | -2.1 points |
RXT's operating margin was −2% last quarter, up 3 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over RXT on cash generation, producing positive trailing cash flow while its opponent burns cash.
RXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2M | -97% |
| Q2 2026 | -$48.3M | -$35.9M |
| Q1 2026 | -$9.4M | -319% |
| Q4 2025 | $56M | +63% |
| Q3 2025 | $42.7M | +56% |
| Q2 2025 | -$12.4M | +$2.1M |
| Q1 2025 | $4.3M | +$122.7M |
| Q4 2024 | $34.4M | -10% |
RXT's free cash flow was −$500,000 over the past year, against $69M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over RXT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
RXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +6.2M shares |
| 1 year | +6.6% | +15.9M shares |
| 3 years | +19% | +40.3M shares |
| 5 years | +22% | +47M shares |
| Available history | +1463% | +240M shares |
RXT has 256M diluted shares, up 6.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $26.9M |
| Q1 2022 | $4.1M |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over RXT on leverage, with a lower net debt burden relative to earnings.
RXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 21.3x | High |
| Q2 2026 | 19.1x | High |
| Q1 2026 | 14.1x | High |
| Q4 2025 | 13.4x | High |
| Q3 2025 | 15.6x | High |
| Q2 2025 | 92.0x | High |
| Q1 2020 | 5.6x | High |
| Q4 2019 | 5.5x | High |
RXT's net debt is more than 20 years of its operating earnings (EBITDA), up from 16 years a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
RXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.4 | Neutral |
| Stochastic | 10.7 | Oversold |
RXT's weekly RSI is 46 (neutral) and its Stochastic is 11 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
RXT PE vs Technology Sector
RXT has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
RXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.23 | 6.8% below |
| 20 week MA | $3.74 | 20% below |
| 50 week MA | $2.91 | 3.4% above |
| 100 week MA | $2.28 | 32% above |
| 200 week MA | $2.18 | 38% above |
RXT has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
RXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $19.9 | +29% |
| 2021 | $19.9 | $14.2 | -29% |
| 2022 | $14.2 | $2.64 | -81% |
| 2023 | $2.64 | $2.00 | -24% |
| 2024 | $2.00 | $2.21 | +10% |
| 2025 | $2.21 | $0.98 | -56% |
| 2026 YTD | $0.98 | $3.01 | +207% |
RXT has the edge over NVDA on returns for 2026, with the stronger performance.